Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Self-Injurious Skin Picking
NCT00115011Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in Excoriation disorder (SPD), sponsored by Massachusetts General Hospital. Started Sep 2002; status: completed.
02
Drugs
escitalopram
03
Conditions
Excoriation disorder (SPD)
Beyond the preview
Go deeper on NCT00115011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115011.